8-K: Oragenics Reschedules 2025 Annual Meeting to June 29

Oragenics, Inc. announced a change in the date for its 2025 Annual Meeting of Shareholders to June 29, 2026, setting a new deadline for shareholder proposals.

Summary

• The Board of Directors of Oragenics, Inc. determined to schedule the 2025 Annual Meeting of Shareholders for June 29, 2026.
• The new meeting date is more than 30 days from the anniversary date of the 2024 Annual Meeting of Shareholders, necessitating this disclosure under Rule 14a-5(f) of the Exchange Act.
• A new deadline for shareholder proposals intended for inclusion in the 2025 proxy statement has been set for May 1, 2026.
• Shareholder proposals or nominations must be delivered to Oragenics, Inc., Attn: Corporate Secretary, 9015 Town Center Parkway, Suite 143, Lakewood Ranch, Florida 34202.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, procedural announcement related to corporate governance, with no direct financial implications or significant positive/negative sentiment.

Future Outlook

The company expects to begin printing and sending its proxy materials for the 2025 Annual Meeting sometime after the May 1, 2026, shareholder proposal deadline.

Management Comments

• The Board of Directors determined it is in the best interest of the Company to schedule the 2025 Annual Meeting of Shareholders for June 29, 2026.

Industry Context

StockSavvy.ai notes this is a standard procedural update for public companies, ensuring compliance with SEC rules regarding shareholder meetings and proxy solicitations when the meeting date shifts significantly from its anniversary.

Corporate Governance

Stakeholder Impact

• Shareholders are impacted by the new date for the 2025 Annual Meeting and the revised deadline for submitting proposals for inclusion in the proxy statement.

Next Steps

• The company will set the record date, time, and location for the 2025 Annual Meeting, to be disclosed in the proxy statement.
• The company expects to begin printing and sending its proxy materials for the 2025 Annual Meeting.
• The 2025 Annual Meeting of Shareholders will be held on June 29, 2026.

Key Dates

Recommendation

This filing is a procedural update regarding the annual shareholder meeting and does not contain any new financial or operational information that would warrant a change in investment recommendation. The company's fundamental outlook remains unchanged based on this announcement.

Keywords

Oragenics, OGEN, Annual Meeting, Shareholder Meeting, Proxy Statement, Corporate Governance, SEC Filing, 8-K